They say it’s ‘unstoppable’ – How I made 43,509%

Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.

Barry Canton Biography and Net Worth

Major Shareholder of Ginkgo Bioworks

Barry is responsible for overall foundry technology strategy and direction. He holds a PhD in Biological Engineering from MIT, where his thesis focused on refinement of standard biological parts and the interactions between a host cell and an engineered genetic circuit. At MIT, he was involved with the Synthetic Biology Working Group that was instrumental in catalyzing the new field. He also holds an MEngSc in Mechanical Engineering from University College Dublin.

What is Barry Canton's net worth?: The estimated net worth of Barry Canton is at least $10.64 million as of December 20th, 2023. Dr. Canton owns 12,374,554 shares of Ginkgo Bioworks stock worth more than $10,643,354 as of April 27th. This net worth estimate does not reflect any other assets that Dr. Canton may own. Learn More about Barry Canton's net worth.
How do I contact Barry Canton?: The corporate mailing address for Dr. Canton and other Ginkgo Bioworks executives is 955 Fifth Avenue, New York NY, 10075. Ginkgo Bioworks can also be reached via phone at 877-442-5362 and via email at [email protected]. Learn More on Barry Canton's contact information.
Has Barry Canton been buying or selling shares of Ginkgo Bioworks?: Barry Canton has not been actively trading shares of Ginkgo Bioworks during the last quarter. Most recently, Barry Canton sold 37,650 shares of the business's stock in a transaction on Wednesday, December 20th. The shares were sold at an average price of $1.79, for a transaction totalling $67,393.50. Following the completion of the sale, the insider now directly owns 12,374,554 shares of the company's stock, valued at $22,150,451.66. Learn More on Barry Canton's trading history.
Who are Ginkgo Bioworks' active insiders?: Ginkgo Bioworks' insider roster includes Barry Canton (Major Shareholder), Marijn Dekkers (Director), Mark Dmytruk (Insider), Christian Henry (Director), Jason Kelly (Insider), and Reshma Shetty (Insider). Learn More on Ginkgo Bioworks' active insiders.
Are insiders buying or selling shares of Ginkgo Bioworks?: In the last twelve months, Ginkgo Bioworks insiders bought shares 1 times. They purchased a total of 400,000 shares worth more than $512,000.00. In the last twelve months, insiders at the sold shares 71 times. They sold a total of 3,788,984 shares worth more than $26,732,779.17. The most recent insider tranaction occured on April, 2nd when insider Mark E Dmytruk sold 51,169 shares worth more than $53,727.45. Insiders at Ginkgo Bioworks own 15.1% of the company. Learn More about insider trades at Ginkgo Bioworks.
Information on this page was last updated on 4/2/2024.

Barry Canton Insider Trading History at Ginkgo Bioworks

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/20/2023	Sell	37,650	$1.79	$67,393.50	12,374,554
12/13/2023	Sell	36,829	$1.34	$49,350.86	12,413,025
12/6/2023	Sell	37,650	$1.32	$49,698.00	12,449,854
11/24/2023	Sell	37,650	$1.42	$53,463.00	12,525,144
11/22/2023	Sell	37,650	$1.40	$52,710.00	12,525,154
11/15/2023	Sell	37,650	$1.54	$57,981.00	12,562,804
10/18/2023	Sell	37,650	$1.69	$63,628.50	12,713,404
10/11/2023	Sell	37,650	$1.76	$66,264.00	12,751,054
9/27/2023	Sell	37,650	$1.83	$68,899.50	12,826,354
9/6/2023	Sell	37,650	$2.23	$83,959.50	12,939,304
8/30/2023	Sell	37,650	$2.22	$83,583.00	12,976,954
8/23/2023	Sell	37,650	$1.74	$65,511.00	13,014,604
8/2/2023	Sell	37,650	$2.07	$77,935.50	13,127,554
7/26/2023	Sell	37,650	$2.38	$89,607.00	13,165,204
7/12/2023	Sell	37,650	$2.09	$78,688.50	13,240,504
7/5/2023	Sell	37,650	$1.81	$68,146.50	13,278,154
6/28/2023	Sell	37,650	$1.70	$64,005.00	13,315,804
6/14/2023	Sell	37,650	$1.95	$73,417.50	13,391,104
3/14/2023	Sell	75,300	$1.33	$100,149.00	13,918,194
2/8/2023	Sell	128,864	$1.88	$242,264.32	14,106,444
1/31/2023	Sell	149,554	$1.85	$276,674.90	14,893,808
1/27/2023	Sell	145,907	$1.82	$265,550.74	15,199,374
1/25/2023	Sell	158,748	$1.73	$274,634.04	15,534,102
1/23/2023	Sell	143,808	$1.75	$251,664.00	15,846,844
1/19/2023	Sell	199,843	$1.71	$341,731.53	16,142,857
1/17/2023	Sell	151,530	$1.86	$281,845.80	16,497,505
1/12/2023	Sell	190,343	$1.70	$323,583.10	16,806,654
1/10/2023	Sell	157,798	$1.50	$236,697.00	17,143,446
1/4/2023	Sell	37,650	$1.56	$58,734.00	17,750,024
12/19/2022	Sell	206,448	$1.67	$344,768.16	18,802,386
12/15/2022	Sell	103,547	$1.61	$166,710.67	19,110,257
12/13/2022	Sell	98,934	$1.89	$186,985.26	19,316,149
12/8/2022	Sell	97,204	$1.79	$173,995.16	19,611,244
12/6/2022	Sell	103,392	$1.73	$178,868.16	19,809,357
11/29/2022	Sell	96,434	$1.90	$183,224.60	20,221,860
11/23/2022	Sell	99,797	$1.99	$198,596.03	20,318,294
11/21/2022	Sell	103,764	$2.10	$217,904.40	20,519,903
11/16/2022	Sell	219,088	$2.42	$530,192.96	20,943,633
11/14/2022	Sell	208,632	$2.72	$567,479.04	21,375,164
11/10/2022	Sell	186,028	$2.46	$457,628.88	21,781,760
11/8/2022	Sell	193,616	$2.46	$476,295.36	22,175,747
11/4/2022	Sell	204,906	$2.51	$514,314.06	22,575,172
11/1/2022	Sell	196,308	$2.77	$543,773.16	22,780,078
10/27/2022	Sell	204,478	$2.71	$554,135.38	23,373,592
10/24/2022	Sell	206,503	$2.48	$512,127.44	23,954,649
10/20/2022	Sell	196,721	$2.47	$485,900.87	24,362,523
10/18/2022	Sell	198,051	$2.64	$522,854.64	24,771,073
10/14/2022	Sell	215,948	$2.62	$565,783.76	25,164,441
10/12/2022	Sell	211,065	$2.81	$593,092.65	25,587,660
10/10/2022	Sell	213,575	$2.88	$615,096.00	25,999,160
10/3/2022	Sell	343,072	$3.12	$1,070,384.64	26,212,735

Barry Canton Buying and Selling Activity at Ginkgo Bioworks

Ginkgo Bioworks Company Overview

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $0.86

$0.76

$0.87

50 Day Range

MA: $1.13

$0.78

$1.54

2 Week Range

Now: $0.86

$0.74

$2.55

Volume

71,222,534 shs

Average Volume

31,559,994 shs

Market Capitalization

$1.85 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.35

They say it’s ‘unstoppable’ – How I made 43,509%

From Investing Daily | Ad

Click here now for the full story.